comparemela.com

Latest Breaking News On - Eduardo ramacciotti - Page 1 : comparemela.com

Full-Dose Antithrombotic Aids Selected COVID-19 ICU Patients

Compared with reduced-dose prophylaxis, full-dose anticoagulation cut thrombotic events but also boosted bleeding in patients with COVID-19 who needed ICU admission.

United statesComunidad autonoma de catalunaDaiichi sankyoDavidd bergJohnw eikelboomEduardo ramacciottiAmerican society of hematologyMcmaster universityEuropean society of cardiologySanta casa school of medicineAmerican societyEuropean societySanta casa schoolIncreased win ratio with fullNew england journalMobility bio

COVID-PACT: Full-Dose Anticoagulation Improves Outcomes in Critical COVID-19

For less-sick patients, results from the ACT trials showed no benefits with colchicine, aspirin, or rivaroxaban plus aspirin.

United statesSao pauloComunidad autonoma de catalunaDphil brighamErin bohulaDavid bergJohn eikelboomSanjit jollyAlida caforioEduardo ramacciottiEuropean society of cardiology congressMcmaster universityMd university of sheffieldInternational society on thrombosisPhd university of padovaPhd science valley research institute

Full-Dose Anticoagulation Cuts VTE in Severe COVID-19

But is it worthwhile without a mortality benefit? Trials present complex picture

United statesComunidad autonoma de catalunaJohn william eikelboomDavid bergSanjit jollyAlida caforioEduardo ramacciottiMcmaster universityEuropean society of cardiologyInternational society on thrombosisPopulation health research instituteScience valley research institute in santo andrUniversity of paduaEuropean societyGlobal useOpen occluded arteries

Managing Cardiovascular Complications of COVID Vaccination

At a recent conference, cardiologists discussed the management of myopericarditis and myocarditis after SARS-CoV-2 infection, as well as the cardiac rehabilitation process.

Rio de janeiroEstado do rioGodoy bezerraJoelma dominato rocha carvalhoKezen camilo jorgeEduardo ramacciottiBruno rustum andrAloysio de castro state cardiology instituteMedscape coronavirus resource centerRio de janeiro society of cardiologyCoronavirus resourceRio de janeiro societyAndrade de godoy bezerraState civil servant federal hospitalEuropean heart journalDominato rocha carvalho

Rivaroxaban Improves Clinical Outcomes After COVID-19 Hospitalization

Risk for thrombotic events reduced after 35 days of rivaroxaban compared with no extended thromboprophylaxis

Eduardo ramacciottiScience valley research instituteInternational medical prevention registry on venous thromboembolismHealthday newsInternational medical prevention registryVenous thromboembolism

vimarsana © 2020. All Rights Reserved.